Celtic Therapeutics Earmarks $50M For ADC Therapeutics

Private equity firm Celtic Therapeutics is promising a $50 million investment in ADC Therapeutics, a new company that will work closely with Celtic’s other investment Spirogen on antibody-drug conjugates.